Hepatitis E: A disease of reemerging importance

Journal of the Formosan Medical Association

Volumn 114, Issue 8, 2015, Pages 681-690

  Sridhar, Siddharth ^a   Lau, Susanna K P ^a,b   Woo, Patrick C Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epidemiology; Hepatitis E; Immunization; Immunocompromised patient

Indexed keywords

HEPATITIS VACCINE; RECOMBINANT VACCINE;

ANTIVIRAL THERAPY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CARRIER; DISEASE TRANSMISSION; GENOTYPE; HEPATITIS E; HUMAN; IMMUNOCOMPROMISED PATIENT; NONHUMAN; PIG; PREVALENCE; REVIEW; RISK FACTOR; VACCINATION; VIROLOGY; ZOONOSIS; ANIMAL; CLINICAL TRIAL (TOPIC); HEPATITIS E VIRUS; TRANSMISSION; VETERINARY;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE RESERVOIRS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; SWINE; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES; ZOONOSES;

EID: 84940439760     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.02.003     Document Type: Review

References (100)

1. Yamada K., Takahashi M., Hoshino Y., Takahashi H., Ichiyama K., Nagashima S., et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol 2009, 90:1880-1891.
2. World Health Organization. Global prevalence of hepatitis E: a systematic review. Available at: [accessed 24.08.14]. http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.14_eng.pdf.
3. Lo M, Chan WK, Lin AW, Wong KH. Surveillance of viral hepatitis in Hong Kong - 2012 Update Report. [accessed 26.08.14]. http://www.info.gov.hk/hepatitis/doc/hepsurv12.pdf.
4. Johne R., Dremesk P., Reetz J., Heckel G., Hess M., Ulrich R.G. Hepeviridae: An expanding family of vertebrate viruses. Infect Genet Evol 2014, 27:212-229.
5. Meng X.J., Purcell R.H., Halbur P.G., Lehman J.R., Webb D.M., Tsareva T.S., et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997, 94:9860-9865.
6. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res 2007, 127:216-228.
7. Hsieh S.Y., Meng X.J., Wu Y.H., Liu S.T., Tam A.W., Lin D.Y., et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 1999, 37:3828-3834.
8. Takahashi M., Nishizawa T., Miyajima H., Gotanda Y., Iita T., Tsuda F., et al. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol 2003, 84:851-852.
9. Liu P., Li L., Wang L., Bu Q., Fu H., Han J., et al. Phylogenetic analysis of 626 hepatitis E virus (HEV) isolates from humans and animals in China (1986-2011) showing genotype diversity and zoonotic transmission. Infect Genet Evol 2012, 12(12):428-434.
10. Hakze-van der Honing R.W., can Coillie E., Antonis A.F., van der Poel W.H. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011, 6:e22673. http://www.ncbi.nlm.nih.gov/pubmed/21829641.
11. Colson P., Romanet P., Moal V., Borentain P., Purgus R., Benzech A., et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012, 18:1361-1364.
12. Kasorndorkbua C., Guenette D.K., Huang F.F., Thomas P.J., Meng X.J., Halbur P.G. Routes of transmission of swine hepatitis E virus in pigs. J Clin Microbiol 2004, 42:5047-5052.
13. Sonoda H., Abe M., Sugimoto T., Sato Y., Bando M., Fukui E., et al. Prevalence of hepatitis E virus (HEV) infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol 2004, 42:5371-5374.
14. Wiratsudakul A., Sariya L., Prompiram P., Tantawet S., Suraruangchai D., Sedwisai P., et al. Detection and phylogenetic characterization of hepatitis E virus genotype 3 in a captive wild boar in Thailand. J Zoo Wildl Med 2012, 43:640-644.
15. Okano H., Nakano T., Sugimoto K., Takahashi K., Nagashima S., Takahashi M., et al. High genomic similarity between European type hepatitis E virus subgenotype 3e strains isolates from an acute hepatitis patient and a wild boar in Mie, Japan. Hepatol Res 2014, 44:694-699.
16. Lhomme S., Dubois M., Abravanel F., Top S., Bertagnoli S., Guerin J.L., et al. Risk of zoonotic transmission of HEV from rabbits. J Clin Virol 2013, 58:257-262.
17. He J., Innis B.L., Shrestha M.P., Clayson E.T., Scott R.M., Linthicum K.J., et al. Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. J Clin Microbiol 2002, 40:4493-4498.
18. Johne R., Pienge-Bönig A., Hess M., Ulrich R.G., Reetz J., Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol 2010, 91:750-758.
19. Lack J.B., Volk K. Van Den Bussche RA. Hepatitis E virus genotype 3 in wild rats, United States. Emerg Infect Dis 2012, 18:1268-1273.
20. Mulyanto, Depamede S.N., Sriasih M., Takahashi M., Nagashima S., Jirintai S., et al. Frequent detection and characterization of hepatitis E virus variants in wild rats (Rattus rattus) in Indonesia. Arch Virol 2013, 158:87-96.
21. Li W., Guan D., Su J., Takeda N., Wakita T., Li T.C., et al. High prevalence of rat hepatitis E virus in wild rats in China. Vet Microbiol 2013, 165:275-280.
22. Nidaira M., Takahashi K., Ogura G., Taira K., Okano S., Kudaka J., et al. Detection and phylogenetic analysis of hepatitis E viruses from mongooses in Okinawa, Japan. J Vet Med Sci 2012, 74:1665-1668.
23. Smith D.B., Simmonds P., Jameel S., Emerson S.U., Harrison T.J., Meng X.J., et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 2014, 95:2223-2232.
24. de Paula V.S., Wiele M., Mbunkah A.H., Daniel A.M., Kingsley M.T., Schmidt-Chanasit J. Hepatitis E virus genotype 3 strains in domestic pigs, Cameroon. Emerg Infect Dis 2013, 19:666-668.
25. Kalba M., Colson P., Musongela J.P., Tshiolo L., Davoust B. Detection of hepatitis E virus of genotype 3 in a farm pig in Kinshasa (Democratic Republic of the Congo). Infect Genet Evol 2010, 10:154-157.
26. Drexler J.F., Seelen A., Corman V.M., Fumie Tateno A., Cottontail V., Melim Zerbinati R., et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol 2012, 86:9134-9147.
27. Raj V.S., Smits S.L., Pas S.D., Provacia L.B., Moorman-Roest H., Osterhaus A.D., et al. Novel hepatitis E virus in ferrets, the Netherlands. Emerg Infect Dis 2012, 18:1369-1370.
28. Kwon H.M., Sung H.W., Meng X.J. Serological prevalence, genetic identification, and characterization of the first strains of avian hepatitis E virus from chickens in Korea. Virus Genes 2012, 45:237-245.
29. Hsu I.W., Tsai H.J. Avian hepatitis E virus in chickens, Taiwan, 2013. Emerg Infect Dis 2014, 20:149-151.
30. Zhao Q., Zhou E.M., Dong S.W., Qiu H.K., Zhang L., Hu S.B. Analysis of avian hepatitis E virus from chickens, China. Emerg Infect Dis 2010, 16:1469-1472.
31. Bilic I., Jaskulska B., Basic A., Morrow C.J., Hess M. Sequence analysis and comparison of avian hepatitis E viruses from Australia and Europe indicate the existence of different genotypes. J Gen Virol 2009, 90:863-873.
32. Agunos A.C., Yoo D., Youssef S.A., Ran D., Binnington B., Hunter D.B. Avian hepatitis E virus in an outbreak of hepatitis-splenomegaly syndrome and fatty liver haemorrhage syndrome in two flaxseed-fed layer flocks in Ontario. Avian Pathol 2006, 35:404-412.
33. Haqshenas G., Shivaprasad H.L., Woolcock P.R., Read D.H., Meng X.J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001, 82:2449-2462.
34. Sprygin A.V., Nikonova Z.B., Zinyakov N.G. Avaian hepatitis E virus identified in Russian chicken flocks exhibits high genetic divergence based on the ORF2 capsid gene. Avian Pathol 2012, 41:459-463.
35. Lin J., Norder H., Uhihorn H., Belák S., Widén F. Novel hepatitis E like virus found in Swedish moose. J Gen Virol 2014, 95:557-570.
36. Medrano C., Boadelia M., Barrios H., Cantú A., Garcia Z., de la Fuente J., et al. Zoonotic pathogens among white-tailed deer, northern Mexico, 2004-2009. Emerg Infect Dis 2012, 18:1372-1374.
37. Rutjes S.A., Lodder-Verschoor F., Lodder W.J., van der Giessen J., Reesink H., Bouwknegt M., et al. Seroprevalence and molecular detection of hepatitis E virus in wild boar and red deer in The Netherlands. J Virol Methods 2010, 168:197-206.
38. Woo P.C., Lau S.K., Teng J.L., Tsang A.K., Joseph M., Wong E.Y., et al. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis 2014, 20:1044-1048.
39. Lee J.T., Shao P.L., Chang L.Y., Xia N.S., Chen P.J., Lu C.Y., et al. Seroprevalence of hepatitis E virus infection among swine farmers and the general population in rural Taiwan. PLoS One 2013, 8:e67180. http://www.ncbi.nlm.nih.gov/pubmed/23840620.
40. Liang H., Su S., Deng S., Gu H., Ji F., Wang L., et al. The prevalence of hepatitis E virus infections among swine, swine farmers and the general population in Guangdong Province, China. PLoS One 2014, 9:e88106. http://www.ncbi.nlm.nih.gov/pubmed/24520348.
41. Meng X.J. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003, 278:185-216.
42. Tei S., Kitajima N., Ohara S., Inoue Y., Miki M., Yamatani T., et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J Med Virol 2004, 74:67-70.
43. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
44. Said B., Ijaz S., Kafatos G., Booth L., Thomas H.L., Walsh A., et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009, 15:1738-1744.
45. Nishizawa T., Takahashi M., Mizuo H., Miyajima H., Gotanda Y., Okamoto H. Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99% identity over the entire genome. J Gen Virol 2003, 84:1245-1251.
46. Li T.C., Chijiwa K., Sera N., Ishibashi T., Etoh Y., Shinohara Y., et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005, 11:1958-1960.
47. Berto A., Martelli F., Grierson S., Banks M. Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerg Infect Dis 2012, 18:1358-1360.
48. Berto A., Grierson S., Hakze-van der Honing R., Martelli F., Johne R., et al. Hepatitis E virus in pork liver sausage, France. Emerg Infect Dis 2013, 19:264-266.
49. Feagins A.R., Opriessnig T., Guenette D.K., Halbur P.G., Meng X.J. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007, 88:912-917.
50. Centre for Food Safety Food and Environmental Hygiene Department. Hepatitis E virus in fresh pig livers. Risk Assessment Studies Report HKSAR 2010, 44:39.
51. Crossan C., Baker P.J., Craft J., Takeuchi Y., Dalton H.R., Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2012, 18:2085-2087.
52. Shukla P., Chauhan U.K., Naik S., Anderson D., Aggarwal R. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat 2007, 14:310-317.
53. Wibawa I.D., Suryadarma I.G., Mulyanto, Tsuda F., Matsumoto Y., Ninomiya M., et al. Identification of genotype 4 hepatitis E virus strains from a patient with acute hepatitis E and farm pigs in Bali, Indonesia. J Med Virol 2007, 79:1138-1146.
54. Abro A.H., Abdou A.M., Saleh A.A., Ustadi A.M., Hussaini H.S. Hepatitis E: a common cause of acute viral hepatitis. J Pak Med Assoc 2009, 59:92-94.
55. Crossan C., Scobie L., Godwin J., Hunter J.G., Hawkes T., Dalton H.R. Hepatitis E virus and porcine-derived heparin. Emerg Infect Dis 2013, 19:686-688.
56. Han J., Zeng H., Wang L., Liu P., Liu L., Xia J., et al. Hepatitis E virus infection in farmed rabbits and swine in the Eastern Chinese city Lianyungang: Showing no potential interspecies transmission. J Med Virol 2014, 86:1898-1904.
57. Feagins A.R., Opriessnig T., Guenette D.K., Halbur P.G., Meng X.J. Inactivation of infectious hepatitis E virus present in commercial pig livers sold in local grocery stores in the United States. Int J Food Microbiol 2008, 123:32-37.
58. Busby S.A., Crossan C., Godwin J., Petersen B., Galli C., Cozzi E., et al. Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation. Xenotransplantation 2013, 20:188-192.
59. Kamar N., Selves J., Mansuy J.M., Quezzani L., Péron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
60. Versluis J., Pas S.D., Agteresch H.J., de Man R.A., Maaskant J., Schipper M.E., et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013, 122:1079-1086.
61. Halac U., Béland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012, 160:871-874.
62. Pischke S., Stiefel P., Franz B., Bremer B., Suneetha P.V., Heim A., et al. Chronic hepatitis e in heart transplant recipients. Am J Transpl 2012, 12:3128-3133.
63. Riezebos-Brillman A., Puchhammer-Stöckl E., van der Weide H.Y., Haagsma E.B., Jaksch P., Bejvl I., et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013, 32:341-346.
64. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
65. Haagsma E.B., Niesters H.G., van den Berg A.P., Riezebos-Brilman A., Porte R.J., Vennema H., et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009, 15:1225-1228.
66. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim A., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
67. Moal V., Legris T., Burtey S., Morange S., Purgus R., Dussoi B., et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013, 85:462-471.
68. Abravanel F., Lhomme S., Chapuy-Regaud S., Mansuy J.M., Muscari F., Sallusto F., et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014, 209:1900-1906.
69. le Coutre P., Meisel H., Hofmann J., Röcken C., Vuong G.L., Neuburger S., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
70. Neukam K., Barreiro P., Macías J., Avellón A., Cifuentes C., Martín-Carbonero L., et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013, 57:465-468.
71. Hajji H., Gérolami R., Solas C., Moreau J., Colson P. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents 2013, 41:595-597.
72. Jagjit Singh G.K., Ijaz S., Rockwood N., Farnworth S.P., Devitt E., Atkins M., et al. Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013, 66:103-106.
73. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
74. Dalton H.R., Keane F.E., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011, 155:479-480.
75. Tamura A., Shimizu Y.K., Tanaka T., Kuroda K., Arakawa Y., Takahashi K., et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007, 37:113-120.
76. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009, 150:430-431.
77. Geng Y., Zhang H., Huang W., J Harrison T., Geng K., Li Z., et al. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon 2014, 14:e15618. http://www-ncbi-nlm-nih-gov.eproxy1.lib.hku.hk/pubmed/24596581.
78. Abravanel F., Chapuy-Regaud S., Lhomme S., Miedougé M., Peron J.M., Alric L., et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013, 58:624-628.
79. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
80. Hewitt P.E., Ijaz S., Brailsford S.R., Brett R., Dicks S., Haywood B., et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014, 384:1766-1773.
81. Schlosser B., Stein A., Neuhaus R., Pahl S., Ramez B., Krüger D.H., et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012, 56:500-502.
82. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
83. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139:1612-1618.
84. Alric L., Bonnet D., Beynes-Rauzy O., Izopet J., Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011, 106:1562-1563.
85. Kamar N., Izopet J., Tripon S., Bismuth M., Hillaire S., Dumortier J., et al. Ribavirin for chronic hepatitis E virus infection in transplant infection. N Engl J Med 2014, 370:1111-1120.
86. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
87. Goyal R., Kumar A., Panda S.K., Paul S.B., Acharya S.K. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012, 17:1091-1096.
88. Pischke S., Hardtke S., Bode U., Birkner S., Chatzikyrkou C., Kauffmann W., et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013, 33:722-726.
89. Robbins A., Lambert D., Ehrhard F., Brodard V., Hentzien M., Lebrun D., et al. Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin. J Clin Virol 2014, 60:422-423.
90. Guner R., Hasanoglu I., Tasyaran M.A., Yapar D., Keske S., Guven T., et al. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?. Vector Borne Zoonotic Dis 2014, 14:601-605.
91. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23:2893-2901.
92. Zhang X., Wei M., Pan H., Lin Z., Wang K., Weng Z., et al. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®. Vaccine 2014, 32:4039-4050.
93. Wei M., Zhang X., Yu H., Tang Z.M., Wang K., Li Z., et al. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes. Vaccine 2014, 32:2859-2865.
94. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomized, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
95. Huang S.J., Liu X.H., Zhang J., Ng M.H. Protective immunity against HEV. Curr Opin Virol 2014, 5:1-6.
96. Wu T., Huang S.J., Zhu F.C., Zhang X.F., Ai X., Yan Q., et al. Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults. Hum Vaccine Immunother 2013, 9:2474-2479.
97. Wu T., Zhu F.C., Huang S.J., Zhang X.F., Wang Z.Z., Zhang J., et al. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012, 55:2038.
98. Phase IV clinical trial of recombinant hepatitis E vaccine. Available at: [accessed 26.08.14]. http://clinicaltrials.gov/show/NCT02189603.
99. Liu P., Du R.J., Wang L., Han J., Liu L., Zhang Y.I., et al. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine. PLoS One 2014, 9:e87600. http://www-ncbi-nlm-nih-gov.eproxy2.lib.hku.hk/pubmed/24498149.
100. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.